Intro to NMJ Pharmacology Flashcards

1
Q

cisatracurium

A

nondepolarizing isoquinoline derivative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tubocurarine

A

nondepolarizing isoquinoline derivative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pancuronium

A

steroid derivative nondepolarizing agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

rocuronium

A

steroid derivative nondepolarizing agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

vecuronium

A

steroid derivative nondepolarizing agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

succinylcholine

A

depolarizing neuromuscular blocking agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dantrolene

A

spasmolytic - muscle relaxant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

echothiophate

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

edrophonium

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

neostigmine

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

physostigmine

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pyridostigmine

A

acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

atropine

A

antimuscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pralidoxime

A

cholinesterase reactivator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

spasmolytics

A

centrally acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nondepolarizing neuromuscular blocking agent

A

agonist at nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

depolarizing neuromuscular blocking agent

A

excess of depolarizing agonist

ex. succinylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

all neuromuscular blocking agents

A

highly polar and inactive orally

must be given parenterally**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

quaternary nitrogen

A

make poorly lipid soluble - limit CNS entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

kidney excretion

A

longer half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

liver excretion

A

shorter half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

rocuronium

A

fast onset and short duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

diaphragm

A

last muscle to be paralyzed and quickest to recover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

reversal of neuromuscular blockade

A

reversed with ACh or succinylcholine

also - may give cholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

edrophonium

A

pure cholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

neostigmine and pyridostigmine

A

cholinesterase inhibitor AND increase release of ACh at motor nerve terminal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

large dose of neuromuscular blockade

A

enter pore of nAChR - more intense blockade - diminish ability of acetylcholinesterase inhibitor to antagonize effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

adverse of nondepolarizing agents

A

histamine release

-wheals, bronchospasm, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

tubocuraine

A

declined use

  • because of histamine release
  • and very long duration of action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

inhaled anesthetic

A

potentiate neuromuscular blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

aging and neuromuscular response

A

longer duration of action with nondepolarizing agents in older patient - bc of reduced hepatic and renal function

so need to decrease dose**

usually age >70yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

myasthenia gravis

A

enhanced effect of neuromuscular blockade

33
Q

severe burn and upper motor neuron disease

A

resistant to nondepolarizing agents

need higher dose

34
Q

laudanosine

A

breadown product of atracurium and cisatracurium

high concentration in brain - seizures

35
Q

long acting steroid relaxant

A

pancuronium

high potency

36
Q

intermediate acting steroid relaxant

A

vecuronium and rocuronium

37
Q

steroid nondepolarizing agent for several days in ICU

A

3 hydroxy metabolite can cause prolonged paralysis

38
Q

least tendency for histamine release

A

steroid neuromuscular blocking agents

39
Q

paralysis for >1 hour

A

pancuronium

40
Q

rapid time of onset, intermediate duration, low potency

A

rocuronium

41
Q

rapid onset anesthesia

A

rocuronium

42
Q

2-4 minute onset (slower), intermediate duration, high potency

A

vecuronium

43
Q

succinycholine pharmacokinetics

A

ultra short duration of action

44
Q

phase 1 succinylcholine block

A

depolarizing

depolarized membrane remains depolarized
-flaccid paralysis occurs

augmented by cholinesterase inhibitors

45
Q

phase 2 succinylcholine block

A

desensitizing

initial end plate depolarization decreases and membrane repolarized

membrane unable to depolarize again - bc desensitized

reversed by AChE inhibitors

46
Q

rapid sequence induction

A

succinylcholine

47
Q

adverse effects of succinylcholine

A

cardiac arrhythmia
negative inotropic and chronotropic effect

larger dose - positive effects above

intraocular pressure
intragastric pressure
muscle pain
histamine release

48
Q

CI for succinylcholine

A

fam hx of malignant hyperthermia
myopathies
major burn, multi trauma, denervation

49
Q

black box warning succinylcholine

A

cardiac arrest risk
-health children with undiagnosed skeletal m myopathy

acute rhabdomyolysis, hyperK, ventricular dysrhythmia, cardiac arrest, and even death

50
Q

tx of malignant hyperthermia

A

caused by abnormal release of Ca from stores in skeletal m

tx - dantrolene

51
Q

first choice for rapid sequence intubation

A

succinylcholine

52
Q

MOA dantrolene

A

inhibit RyR calcium channel

blocks release of Ca from SR

53
Q

CI for dantrolene

A

no oral if hepatitis

54
Q

MOA botulinum

A

cleave SNARE complex and block release of ACh

55
Q

cholinesterase inhibitors

A

indirect acting

causes increase in ACh at synapse

56
Q

butyrylcholinesterase

A

pseudocholinesterase

plasma and liver

57
Q

acetylcholinesterase

A

in NMJ

58
Q

edrophonium

A

alcohol AChE inhibitor

binding noncovalent and reversible

59
Q

neostigmine

A

carbamic acid ester AChE inhibitor

noncovalent and reversible binding to AChE

60
Q

pyridostigmine

A

carbamic acid ester AChE inhibitor

noncovalent and reversible binding to AChE

61
Q

physostigmine

A

carbamic acid ester AChE inhibitor

noncovalent and reversible binding to AChE

62
Q

echothiophate

A

organophosphate AChE inhibitor

63
Q

tertiary and uncharged AChE inhibitors

A

CNS distribution

physostigmine

64
Q

quaternary and charged AChE inhibitors

A

no CNS distribution

neostigmine, pyridostigmine, echothiophate

65
Q

alcohol AChE inhibitors

A

short duration of action 2 - 10 mins

66
Q

carbamic acid ester AChE inhibitors

A

30min to 6 hour action

67
Q

organophosphate AChE inhibitors

A

hundreds of hours of action

68
Q

aging

A

breaking of one O-P bonds of inhibitor
-further strengthens interaction

difficulty to break

69
Q

organophosphate and tertiary AChE inhibitors

A

central and peripheral activity

70
Q

tx of myasthenia gravis

A

pyridostigmine
neostigmine
ambenonium

do not cross BBB

dosing based on titrations

71
Q

diagnosis of myasthenia gravis

A

edrophonium test

has been phased out

now - ice pack test - to fix ptosis temoprarily

72
Q

myasthenic vs. cholinergic crisis

A

myasthenic - severe enough for intubation
cholinergic - side effect of excessive AChE inhibitors

differentiate two - edrophonium test

  • myasthenic - symptoms improve
  • cholinergic - symptoms unchanged or worsen
73
Q

paralytic ileus tx

A

AChE inhibitors

74
Q

tx of dementia

A

alzheimer type and parkinson association benefit from AChE inhibitor

75
Q

physostigmine

A

crosses BBB

used as antimuscarinic antidote for intoxication

sx - vasodilation, anhidrosis, mydriasis, delirium, hallucinations

76
Q

homicide and suicide

A

organophosphate and carbamate AChE inhibitors

sx - miosis, salivation, sweating, bronchial constriction, vomiting, diarrhea

route of admin - determines the sx

antidote - atropine - mAChR agonist

77
Q

miosis

A

contraction of pupil

78
Q

cholinesterase regenerator

A

pralidoxime

regenerate active enzyme from organophosphorous cholinesterase complex

give before aging
don’t reverse central effects - doesn’t enter CNS

79
Q

prophylactic pyridostigmine

A

reduce incapacitation and mortality of nerve agent poisoning

for combat use military personnel